June 13, 2016
One of the main source of distrust towards public health authorities is the suspect of hidden connections with the pharmaceutical industry, but, in case of a severe pandemic, an adequate supply of antivirals and vaccines is essential. ASSET asked Norman Begg, GSK Vice President, Head of Scientific Affairs and Public Health, Vaccines, what kind of agreements exist for Public Health Emergencies of International Concern (PHEIC) or of a pandemic, between big pharma and WHO. The answer for the two situations is not the same.
June 30, 2016
Albert Osterhaus, director of the Research Center for Emerging Infections and Zoonoses (RIZ) in Hannover, Germany, and Chairman of the European Working group on Influenza (ESW), is one of the top virologist in the world, who has discovered more than 50 new viruses over the last decades. In this short video he explains why the word “pandemic” can be a cause of misunderstanding between health authorities and the public, as it happened in 2009, when the new emerging flu virus A(H1N1) turned out to be milder than expected in the beginning.
July 13, 2016
Many clinical trials, even those on vaccines, are currently being made without considering the immunological differences that can exist between men and women. Katie Flanagan, senior lecturer of the Department of Immunology at Monash University, in Melbourne, Australia, explains how, and why this needs to be changed.
July 29, 2016
Living poultry markets, common in China and in other eastern countries, are a typical example of how societal factors can be relevant in the spread of infectious diseases. A science-with-and-for-society approach should therefore find a way to solve this problem without fostering people hostility towards authorities. Even if central slaughters would be the simplest solutions, people would not accept them. Ivan Hung, Clinical Associate Professor and Honorary Consultant in the Department of Medicine at the Queen Mary Hospital of the University of Hong Kong, explains how this issue can be dealt with, in the fight against H7N9 bird flu virus and other new strains.
January 18, 2016
The European Union's Seventh Framework Programme for research cofunds ASSET project, a resource in case of infectious threats.
ASSET project provides public health authorities with resources, suggestions and tools that could help to draw and review pandemic and epidemic preparedness plans, both national and transnational - introducing Science-in-Society issues, such as those related to ethics and gender.
It makes available a qualified and diverse network of experts in disaster management, public health and risk communication.
A bridge between stakeholders, public health authorities and general public, also through social media in order to encourage listening, improve dialogue, facilitate mutual learning and enhance mobilization.
Just in case.
Citizens from the eight Countries partner of the ASSET project will gather on September 24th to discuss and express themselves through a public consultation on some of the key topics of the project: